This inventor holds 1 USPTO granted patent. Top assignee: Dna Vec Research Inc.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Yumiko Tokusumi: Innovator in Gene Therapy
Introduction
Yumiko Tokusumi is a prominent inventor based in Ibaraki, Japan. She has made significant contributions to the field of gene therapy through her innovative research and development of viral vectors. Her work focuses on the Paramyxoviridae family of viruses, which has important implications for medical applications.
Latest Patents
Yumiko holds a patent for an "Envelope gene-deficient Paramyxovirus vector." This patent describes the successful recovery of F gene-deficient virus virions using an F gene-deficient Sendai virus genomic cDNA. Furthermore, infectious viral particles deficient in the F gene are constructed using F-expressing cells as helper cells. The patent also details the recovery of F gene and HN gene-deficient virus virions, as well as the production of infectious viral particles using F- and HN-expressing cells. Additionally, the construction of a virus deficient in both the F gene and HN gene is achieved, along with the production of M gene-deficient infectious virus particles. These techniques contribute significantly to the development of vectors of Paramyxoviridae that are usable in gene therapy.
Career Highlights
Yumiko Tokusumi is associated with Dna Vec Research Inc., where she continues to advance her research in viral vectors. Her innovative approaches have positioned her as a key figure in the field of gene therapy, particularly in the development of viral vectors that can be utilized for therapeutic purposes.
Collaborations
Yumiko collaborates with notable colleagues, including Kaio Kitazato and Tsugumine Shu. Their combined expertise enhances the research efforts at Dna Vec Research Inc. and contributes to the advancement of gene therapy technologies.
Conclusion
Yumiko Tokusumi's work in developing gene-deficient Paramyxovirus vectors represents a significant advancement in gene therapy. Her innovative research and collaborations continue to pave the way for future breakthroughs in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile